U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Wells G, Coyle D, Cameron C, et al. Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Apr 9.

Cover of Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation

Safety, Effectiveness, and Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation [Internet].

Show details

ABBREVIATIONS

AF

atrial fibrillation

CIHR

Canadian Institutes of Health Research

CI

confidence interval

CrI

credibility interval

CRNM

clinically relevant non-major

CV

cardiovascular

DARE

Database of Abstracts of Reviews of Effects

DSEN

Drug Safety and Effectiveness Network

FDA

Food and Drug Administration

FXa

factor Xa

GI

gastrointestinal

GRADE

Grading of Recommendations Assessment, Development and Evaluation

GLMM

generalized linear mixed models

ICH

intracerebral hemorrhage

INR

international normalized ratio

ISTH

International Society on Thrombosis and Haemostasis

ITT

intention to treat

MCMC

Markov chain Monte Carlo

MI

myocardial infarction

MTC

mixed treatment comparison

λ

maximum willingness to pay

NICE

National Institute for Health and Clinical Excellence

NOAC

new oral anticoagulant

NRS

non-randomized study

NSAID

nonsteroidal antiinflammatory drug

OR

odds ratio

PE

pulmonary embolism

PICO

patient/population, intervention, comparator and outcome

QALY

quality-adjusted life-year

RCT

randomized controlled trial

ROB

risk of bias

SE

systemic embolism

SIGN

Scottish Intercollegiate Guidelines Network

TIA

transient ischemic attack

TTR

time in therapeutic range

VKA

vitamin K antagonist

Copyright © 2012 Canadian Collaborative for Drug Safety, Effectiveness and Network Meta-Analysis.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK169782

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (4.9M)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...